This content is from: Portfolio Cliff Asness Is ‘Confident’ Value Stocks Will Continue to Outperform But there are still some bumps in the road ahead, the AQR co-founder said at the Morningstar Investment Conference. By Hannah Zhang May 17, 2022
This content is from: Premium Element Made a Big Fourth-Quarter Bet on Equities The macro giant headed by Jeffrey Talpins established 36 new long positions. By Stephen Taub February 10, 2022
This content is from: Portfolio Research Affiliates Says ESG Isn’t an Investment Strategy — And That’s a Good Thing A deep dive into ESG-themed indices shows that they’re all but indistinguishable from traditional benchmarks. By Hannah Zhang February 07, 2022
Sponsored J&J To Acquire Synthes For $21.3B Johnson & Johnson will buy medical-device maker, Synthes, for $21.3 billion. April 27, 2011
Sponsored Smith & Nephew Rejects £7B J&J Offer Smith & Nephew has rejected a takeover offer by the U.S. healthcare group, Johnson & Johnson. January 10, 2011
Sponsored J&J In Talks To Buy Swiss Synthes Health giant Johnson & Johnson is in discussions to acquire Swiss surgical products and medical services group, Synthes. April 18, 2011
